ALNYLAM PHARMACEUTICALS, INC. Depreciation & Amortization 2008-2025 | ALNY
What is depreciation & amortization?
Depreciation and amortization represents the non-cash expense of allocating the cost of tangible and intangible assets over their useful lives.
What is ALNYLAM PHARMACEUTICALS, INC.'s current depreciation & amortization?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual depreciation & amortization for 2025 was $54.8M, a 0.54% decline from 2024. ALNYLAM PHARMACEUTICALS, INC. depreciation & amortization for the quarter ending March 31, 2018 was $3.2M.
What was ALNYLAM PHARMACEUTICALS, INC.'s depreciation & amortization in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual depreciation & amortization for 2024 was $55.1M, a 6.78% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s depreciation & amortization in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual depreciation & amortization for 2023 was $51.6M, a 31.97% increase from 2022.
What is ALNYLAM PHARMACEUTICALS, INC.'s 5-year depreciation & amortization CAGR?
ALNYLAM PHARMACEUTICALS, INC. depreciation & amortization grew at a compound annual growth rate (CAGR) of 12.66% from FY2020 to FY2025, going from $30.2M to $54.8M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $54.8M | -0.5% | 10-K |
| FY2024 | $55.1M | +6.8% | 10-K |
| FY2023 | $51.6M | +32.0% | 10-K |
| FY2022 | $39.1M | +6.3% | 10-K |
| FY2021 | $36.8M | +21.9% | 10-K |
| FY2020 | $30.2M | +81.9% | 10-K |
| FY2019 | $16.6M | +29.7% | 10-K |
| FY2018 | $12.8M | +7.6% | 10-K |
| FY2017 | $11.9M | -21.3% | 10-K |
| FY2016 | $15.1M | -20.6% | 10-K |
| FY2015 | $19.1M | +59.7% | 10-K |
| FY2014 | $11.9M | +16.6% | 10-K |
| FY2013 | $10.2M | +13.2% | 10-K |
| FY2012 | $9.0M | +76.3% | 10-K |
| FY2011 | $5.1M | +3.7% | 10-K |
| FY2010 | $4.9M | -17.5% | 10-K |
| FY2009 | $6.0M | +4.6% | 10-K |
| FY2008 | $5.7M | - | 10-K |